Omega-3 EPA/DHA (Triglyceride)
Which Omega-3 EPA/DHA (Triglyceride) form is best?
See our full ranked comparison — scored by absorption, bioavailability & formulary tier
Quick Answer
What is the best form of Omega-3 EPA/DHA (Triglyceride)?
We compared 1 forms of Omega-3 EPA/DHA (Triglyceride) in our formulary. Browse the comparison table below to find the best-absorbed form for your goals and dosing needs.
All Forms of Omega-3 EPA/DHA (Triglyceride)
| Form | Tier | Form Score | Dose Range | Unit |
|---|---|---|---|---|
| triglyceride | Mapped | 95/100Top Tier | — | — |
Absorption by Form
What is Omega-3 EPA/DHA (Triglyceride)?
Omega-3 EPA/DHA (Triglyceride) is a Fatty Acids supplement available in 1 form.
Not all forms of Omega-3 EPA/DHA (Triglyceride) are equal. The form you choose determines how much Omega-3 EPA/DHA (Triglyceride) actually reaches your tissues, and the difference between the best and worst forms can be substantial. FormulaForge ranks every form by how well it absorbs and how strongly the published research supports it, giving you an evidence-based guide for choosing wisely.
Forms of Omega-3 EPA/DHA (Triglyceride) Compared
Omega-3 EPA/DHA (triglyceride) (Mapped Form) has a bioavailability rating of good absorption.
How to Choose the Right Form
Multiple forms of Omega-3 EPA/DHA (Triglyceride) are available. Start by comparing form ratings — Preferred Forms reflect the strongest bioavailability evidence, and higher-absorption forms deliver more active compound per dose unit.
The appropriate form depends on your individual goals and your healthcare provider’s recommendations. Consult a qualified professional before selecting a supplement form.
Dosing & Safety
Individual dose requirements vary based on health goals, body weight, and existing nutrient intake. Your healthcare provider can help you determine an appropriate amount of Omega-3 EPA/DHA (Triglyceride) for you.
Side Effects: Consult your healthcare provider regarding tolerability, particularly at higher doses.
These statements are based on structure/function research and have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before starting or changing a supplement regimen.
The Science
The following studies and findings inform FormulaForge classifications for Omega-3 EPA/DHA (Triglyceride):
Human trial: re-esterified triglyceride EPA/DHA showed ~124% relative bioavailability vs natural fish-oil triglyceride (100%); ethyl ester lower (~73%), free fatty acid intermediate (~91%). PMID: 20638827
Human crossover: krill oil trended higher than re-esterified TG or ethyl ester for plasma phospholipid EPA incorporation, but the difference was not statistically significant (p=0.057). PMID: 21854650
Dose-matched human RCT: fish oil (ethyl ester and triglyceride) and krill oil produced similar total plasma EPA+DHA, with less than 24% difference between forms. PMID: 26328782
6-month human RCT: EPA/DHA from re-esterified triglycerides significantly lowered fasting serum triglycerides while the same dose as ethyl esters did not. PMID: 21862301
AvailOm L-lysine salt (Lys-FFA) EPA+DHA iAUC was 1.44-fold (0-24h; 95% CI 1.15-1.79, p≤0.004) and 1.57-fold (0-12h) higher than the triglyceride arm. DCR(TG→AvailOm)=1/1.44=0.6944. (Same head-to-head study that anchors the ethyl-ester twin at 1/8.09=0.124.) PMID: 39781273
Dosing Guidance
Individual dose requirements for Omega-3 EPA/DHA (Triglyceride) vary based on health goals, body weight, and existing dietary intake. A qualified healthcare provider can help you determine an appropriate amount for you.
Frequently Asked Questions
What is the best form of Omega-3 EPA/DHA (Triglyceride)?
How much Omega-3 EPA/DHA (Triglyceride) should I take?
What does Omega-3 EPA/DHA (Triglyceride) support?
Is Omega-3 EPA/DHA (Triglyceride) safe?
Ready to formulate with Omega-3 EPA/DHA (Triglyceride)?
Build your personalized formula with research-backed dosing.
Start My FormulaCompare & Learn More
References
- Human trial: re-esterified triglyceride EPA/DHA showed ~124% relative bioavailability vs natural fish-oil triglyceride (100%); ethyl ester lower (~73%), free fatty acid intermediate (~91%). PubMed
- Human crossover: krill oil trended higher than re-esterified TG or ethyl ester for plasma phospholipid EPA incorporation, but the difference was not statistically significant (p=0.057). PubMed
- Dose-matched human RCT: fish oil (ethyl ester and triglyceride) and krill oil produced similar total plasma EPA+DHA, with less than 24% difference between forms. PubMed
- 6-month human RCT: EPA/DHA from re-esterified triglycerides significantly lowered fasting serum triglycerides while the same dose as ethyl esters did not. PubMed
- AvailOm L-lysine salt (Lys-FFA) EPA+DHA iAUC was 1.44-fold (0-24h; 95% CI 1.15-1.79, p≤0.004) and 1.57-fold (0-12h) higher than the triglyceride arm. DCR(TG→AvailOm)=1/1.44=0.6944. (Same head-to-head study that anchors the ethyl-ester twin at 1/8.09=0.124.) PubMed
FormulaForge formulates and sells supplements containing the ingredients discussed on this page. Our formulary recommendations are based on peer-reviewed bioavailability research. All cited studies are independently verifiable.